Dose-Dependent Effects of a Novel Selective EP<sub>4</sub> Prostaglandin Receptor Agonist on Treatment of Critical Size Femoral Bone Defects in a Rat Model

Dose-Dependent Effects of a Novel Selective EP<sub>4</sub> Prostaglandin Receptor Agonist on Treatment of Critical Size Femoral Bone Defects in a Rat Model

Difficulties in treating pseudarthrosis and critical bone defects are still evident in physicians’ clinical routines. Bone morphogenetic protein 2 (BMP-2) has shown promising osteoinductive results but also considerable side effects, not unexpected given that it is a morphogen. Thus, the bone regene...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Corina Vater, Elisabeth Mehnert, Henriette Bretschneider, Julia Bolte, Lisa Findeisen, Lucas-Maximilian Matuszewski, Stefan Zwingenberger
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
critical-sized bone defect
bone regeneration
tissue regeneration
scaffold
EP<sub>4</sub> receptor agonist
BMP-2
Biology (General)
QH301-705.5
Acceso en línea:https://doaj.org/article/71d9ae15f7874ec19e2ad0652a02c8b8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares